Encyclopedia

  • Targeting of an antitumor agent, RS-1541 (palmitoyl-rhizoxin), via low-density lipoprotein receptor
  • Add time:08/18/2019         Source:sciencedirect.com

    RS-1541 is a 13-O-palmitoyl derivative of rhizoxin, an inhibitor of tubulin polymerization. RS-1541 has been shown to bind preferentially to plasma lipoproteins and to exhibit selective uptake by tumors in mice. We demonstrated that: (1) 99% of RS-1541 bound to human lipoproteins after incubation with human serum, among which the low-density lipoprotein (LDL) fraction attained 10%; (2) RS-1541/LDL complex was obtained by simply incubating human native LDL with a detergent-aided RS-1541 solution; (3) uptake of the [14C]RS-1541/LDL complex in cultured human skin fibroblasts was dependent on the LDL receptor activities of the cells; (4) excess amounts of native LDL or 10 μM monensin, a proton ionophore, significantly inhibited the uptake; and (5) the detergent-aided solution of [14C]RS-1541 showed very low cellular uptake. These results suggest the possibility of LDL as an endogenous targeting carrier of RS-1541 into tumor cells, which have higher LDL receptor activities.

    We also recommend Trading Suppliers and Manufacturers of palmitoyl rhizoxin (cas 135819-69-1). Pls Click Website Link as below: cas 135819-69-1 suppliers


    Prev:Theoretical studies on the dissociation reactions of chloromethyl peroxynitrate
    Next: Correlations between dechlorane plus concentrations in paired hair and indoor dust samples and differences between dechlorane plus isomer concentrations in hair from males and females)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View